Special Issue "Psychoneuropharmacology"
Deadline for manuscript submissions: 31 October 2021.
Interests: interaction between monoamines and other neuromodulatroy systems (e.g., adrenocortical steroids and endogeneous purines and opioids) in pathophysilogy and treatment of depression and related CNS disorders
The proposed Special Issue will be dedicated to current strategies for the development of new central nervous system (CNS) medications, with a primary focus on antidepressant drugs. Depression is a severe chronic disorder of the CNS, affecting up to 20% of the world population; it is considered by the World Health Organization as the second major reason for disability worldwide. Depression is commonly comorbid with other stress-related mood disorders, such as anxiety, panic, and post-traumatic stress disorder (PTSD). These brain illnesses have similar etiology and pathophysiology. Despite the relative progress in the pharmaceutical treatment of depression and related disorders, the clinical efficacy of the contemporary antidepressant and mood stabilizing drugs remains limited. Different strategies have been proposed for the optimization of treatment of depression and related CNS disorders, such as combinations of existing antidepressant and mood-stabilizing drugs, combinations of pharmaceutical and non-pharmaceutical treatment interventions, development of multimodal drugs acting on several monoamine systems of the brain, as well as searching for new CNS targets other than monoamines (e.g., adrenocortical steroids and endogenous purines and opioids).
Dr. Eliyahu Dremencov
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Stress-related CNS disorders
- Pharmaceutical and non-pharmaceutical treatment strategies
- Adrenocortical steroids
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.